INFRINGEMENT DETERMINATIONS AND DESIGNING AROUND EXISTING PATENTS

-
Good article on INFRINGEMENT DETERMINATIONS AND DESIGNING AROUND EXISTING PATENTS

Comments

Post a Comment

Popular posts from this blog

LICENSING PROCESS

-
The licensing plan First, you need to write down a specific plan. More specifically: 1. Develop a strategy. Will it be an exclusive or non-exclusive license? Will it be limited to various fields? Will it augment sales after your company launches the product? Will you be licensing a limited number licensees or staging them in? What incentives have you considered? 2. Do a SWOT analysis. This is a term used by licensing experts which means you need to analyze and evaluate your intellectual property’s Strengths, Weaknesses, Opportunities and Threats. This is important, because your licensees will do this and if you’re not prepared, you’ll not be able to handle their questions. With these two steps completed, you will want to start taking action. Next: 1. Find licensees. Use New Product Summaries and the methods discussed in the web pages on marketing inventions. 2. Research interested candidates. Once a candidate is identified, research it to better understand it. 3. Start with a term shee...
Read more

Building the Business Case for Innovation

-
Innovation has transitioned from a “nice to have” to a top priority for most companies because innovation drives organic growth. Like other business processes, innovation can be managed to achieve results. Unlike other business processes, innovation requires introducing risk, embracing failure, and doing things that are counter to most efficiency driving processes. Building a business case for innovation requires addressing these and other differences based on how innovation will be implemented within the organization. Specifying the approach, the impact on everyone in the organization, and the means by which innovation will occur in an organization drives the business case and increases the likelihood of success.... more
Read more

KMX Pharma Production Explorer

-
All pharmaceutical companies have to operate in accordance with FDA regulations. Recently the FDA has issued guidelines that determine quality control standards for the pharmaceutical production process. For these companies this implies that they will have to measure every important parameter within their production process in order to control and optimize it. Oracle technology in combination with KMX provided a valuable insight in the production process. By applying data mining, generating all possible models from the data and analyzing all relationships between the models. Further optimization of the thus generated models provided not only better quality control of the production process, as required by the FDA, but also greatly improved production planning and saved production costs.
Read more